Category Archives: (Midwest Communications, Inc. Syndication Interface) Business News (Master Feed)

By Andrea Shalal WASHINGTON, Feb 23 (Reuters) - Rebuilding Ukraine's economy will cost an estimated $588 billion over the next decade, the World Bank, United Nations, European Commission and the Ukrai...

MEXICO CITY, Feb 23 (Reuters) - Mexico's economic activity expanded in December with all three sectors posting growth, rebounding from a contraction the previous month, the national statistics agency ...

LONDON, Feb 23 (Reuters) - The dollar has lost some, but not all, of its safe-haven value since 2024, ING said in note on Monday, adding however, that it saw no broad deterioration in global demand fo...

By Christy Santhosh Feb 23 (Reuters) - Gilead Sciences will pay as much as $7.8 billion to acquire partner Arcellx in its largest deal since 2020, the biopharma company said on Monday, as it looks to ...

LONDON, Feb 23 (Reuters) - High U.S. import tariffs appear to be here to stay and their full impact represent a meaningful change which is likely to take "many years" to be felt, Bank of England polic...

By Doina Chiacu, Susan Heavey and David Lawder WASHINGTON, Feb 23 (Reuters) - U.S. President Donald Trump on Monday warned countries against backing away from recently negotiated trade deals with the ...

Feb 23 (Reuters) - The U.S. Commerce Department on Monday will reveal a preliminary decision on whether to impose anti-subsidy duties on solar cells and panels imported from India, Laos and Indonesia....

By Mike Dolan Feb 23 - What matters in U.S. and global markets today By Mike Dolan, Editor-At-Large, Finance and Markets It's fair to say financial markets are just as confused about U.S. trade policy...

Feb 23 (Reuters) - Novo Nordisk shares slumped by more than 16% on Monday, wiping away the remaining gains brought by its blockbuster weight-loss drug Wegovy, after the drugmaker said its next-generat...

By Padmanabhan Ananthan Feb 23 (Reuters) - Merck said on Monday it would create a separate division for its cancer business, anchored by its top-selling drug Keytruda, as the U.S. drugmaker braces for...